Effects of disease management programs on functional status of patients with rheumatoid arthritis

被引:21
作者
Badamgarav, E
Croft, JD
Hohlbauch, A
Louie, JS
O'Dell, J
Ofman, JJ
Suarez-Almazor, ME
Weaver, A
White, P
Katz, P
机构
[1] Zynx Hlth Inc, Los Angeles, CA USA
[2] Arthrit Ctr, Chevy Chase, MD USA
[3] Harbor UCLA Med Ctr, Torrance, CA 90509 USA
[4] Univ Nebraska, Med Ctr, Omaha, NE USA
[5] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[6] Baylor Coll Med, Houston, TX 77030 USA
[7] Arthrit Ctr Nebraska, Lincoln, NE USA
[8] Childrens Natl Med Ctr, Washington, DC 20010 USA
[9] Mt Sinai Med Ctr, Miami, FL USA
[10] Miami Heart Inst, Miami, FL USA
来源
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH | 2003年 / 49卷 / 03期
关键词
disease management; effectiveness; rheumatoid arthritis;
D O I
10.1002/art.11120
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To perform a systematic review of the published literature on disease management of rheumatoid arthritis (RA) and to use metaanalysis to estimate the magnitude of benefit these programs have on functional status in patients with RA. Methods. Computerized databases for English articles from 1966 to September 2001 were searched. Two reviewers evaluated 1,029 published titles, identified 11 studies meeting explicit inclusion criteria, and extracted data about study characteristics, interventions used, and outcomes measured. Pooled effect sizes for functional status were calculated using a random-effects model. Results. Four out of 8 disease management programs showed significant improvements in functional status; however, the pooled effect size (ES) was small and statistically non-significant (ES 0.27; 95% confidence interval [95% CI] -0.01, 0.54). Studies with longer intervention durations (>5 weeks) had significantly improved patient functional status (ES 0.49; 95% CI 0.12, 0.86), compared with studies with shorter intervention durations (less than or equal to5 weeks, ES 0.13; 95% CI -0.25, 0.52). Conclusions. There were limited data to support or refute the effectiveness of disease management programs in improving functional status in patients with RA. Additional studies are needed to confirm if a more intensive intervention may be of benefit to patients with RA, as suggested by our study.
引用
收藏
页码:377 / 387
页数:11
相关论文
共 37 条
[21]   New medications for use in patients with rheumatoid arthritis [J].
Moder, KG .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2000, 84 (03) :280-284
[22]  
MULLEN PD, 1987, J RHEUMATOL, V14, P33
[23]  
*NAT COMM VIT HLTH, 2001, CLASS REP FUNCT STAT
[24]  
PARKER JC, 1984, ARCH PHYS MED REHAB, V65, P771
[25]   Rheumatoid arthritis [J].
Ramsburg, KL .
AMERICAN JOURNAL OF NURSING, 2000, 100 (11) :40-43
[26]   THE FILE DRAWER PROBLEM AND TOLERANCE FOR NULL RESULTS [J].
ROSENTHAL, R .
PSYCHOLOGICAL BULLETIN, 1979, 86 (03) :638-641
[27]  
Rosenthal R., 1984, META ANALYTIC PROCED
[28]  
SCHNED ES, 1995, J RHEUMATOL, V22, P1141
[29]   Persistent functional and social benefit 5 years after a multidisciplinary arthritis training program [J].
Scholten, C ;
Brodowicz, T ;
Graninger, W ;
Gardavsky, I ;
Pils, K ;
Pesau, B ;
Eggl-Tyl, E ;
Wanivenhaus, A ;
Zielinski, CC .
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 1999, 80 (10) :1282-1287
[30]   New drugs for the treatment of rheumatoid arthritis [J].
Schuna, AA ;
Megeff, C .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2000, 57 (03) :225-234